PTCT | PTC TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$68.12
+$7.24 (+11.89%)

PTC Therapeutics (PTCT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat below the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits between the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $68.12 vs 50 $65.12 / 200 $70.58
Projection
No cross projected
Test
No active test
Last cross
Death cross 18 Sep 2026 ยท projected 22 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $59.97 vs 50 $71.62 / 200 $48.89
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 10 Mar 2025 ยท projected 15 bars out

4-hour as of 3 Nov 13:30 ET

Price
between the two $68.31 vs 50 $62.46 / 200 $71.23
Projection
No cross projected
Test
No active test
Last cross
Death cross 20 Aug 2026 bar 2 ยท projected 25 bars out ยท tested 3 bars

Cross history

36
crosses on record since 2018
17 golden19 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
18 Sep 2026Death steepdaily22 bars outNot tested
20 Aug 2026Death4-hour25 bars out3 bar cross test
5 Jun 2026Golden4-hour15 bars out3 bar cross test
25 Feb 2026Death4-hour20 bars outNot tested
13 Aug 2025Golden4-hournot projectedโ€”

About PTCT

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$64.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.